The effect of the Covid-19 Pandemic on pediatric urology

Anna Bujons Tur1, Juan Carlos Prieto2, Andrés Gómez-Fraile3

  • 1Department of Urology, Division Urology Pediatric, Fundació Puigvert Barcelona, Spain.

Insights

This review addresses pediatric urology surgical priorities during the pandemic, highlighting limited evidence. It synthesizes available data and guidelines on patient selection, timing, and organization of care.

Area of Science:

  • Pediatric Urology
  • Surgical Guidelines
  • Pandemic Response

Background:

  • Pandemic significantly altered medical and surgical priorities globally.
  • Rapid guidance from scientific societies adapted existing recommendations.
  • Limited scientific evidence exists in pediatric urology.

Purpose of the Study:

  • To review current scientific evidence in pediatric urology during the pandemic.
  • To synthesize recommendations on surgical priorities and patient management.
  • To guide clinical practice in pediatric urology amidst the pandemic.

Main Methods:

  • Literature review of available publications.
  • Analysis of recommendations from major scientific societies.
  • Focus on surgical patient selection, timing, and visit organization.

Main Results:

  • Identified limited but crucial evidence for pediatric urology.
  • Summarized societal recommendations for adapting surgical practices.
  • Highlighted key considerations for patient care organization.

Conclusions:

  • Urgent need for evidence-based adaptation in pediatric urology.
  • Societal guidelines provide a framework for managing surgical patients.
  • Careful organization of patient visits is essential for safety.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
297
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
274
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
175
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
182